Fed. Circ. Takes Issue With Hospira's 11th-Hour Arguments
A Federal Circuit panel didn't seem to be buying Hospira's argument Wednesday that a lower court bungled the law when it nixed the drugmaker's patent for the sedative Precedex, with one...To view the full article, register now.
Already a subscriber? Click here to view full article